|
| |
Saturday, May 5, 2007 |
|
 |
|
 |
| |
| FDA Rejects Merck's Request - Wall Street Journal |
| trag FDA AusschussMercks - barrier Street journal(Subskription) FDA journal road RequestWall Mercks(subscription) points, to NY back - 27 April. 2007 Pfizer its otherso-called Cox-2 pain-satisfying means, Celebrex keep left, on themarket with warnings. The FDA that confirms the Vioxx directly...Quelle: news.google.com FDA Vioxx Vioxx-Wie pain drug- Web MD over the Haufen FDA throws Vioxx Vioxx-Wie the painDrugWebMD - throws 27 April. 2007 over the heaps..., which admit Cox-2as obstacles are, the Vioxx and vioxx celebrex Bextra close -- both removes from USpharmacies -- as well as Celebrex still on the market is...Quelle: news.google.com FDA Arcoxia Mercks -Philadelphia investigating zurueck FDA points investigatingArcoxiaPhiladelphia Mercks, Pa back - points 28 April. nearly $2billion for Merck produced 2007 Vioxx 2003. Only a cox-2 obstacle,Celebrex, in an educated manner by Pfizer Inc., still in the UnitedStates sold... Quelle: news.google.comVerbrauchergruppe says the fact that Celebrex announcementdangers - untertreibt consumer group says scientific Americanthat Celebrex announcement under-drives risksScientific Americans - 9April. 2007 Celebrex and vioxx celebrex Vioxx are both so-called COX-2 of obstacles,the drugs, which are computed on the stomach as pain-satisfying means,as easier, as naproxen and vioxx celebrex ibuprofen... Quelle:news.google.com |
| posted by vioxx celebrex @ Saturday, May 5, 2007
|
|
|
|
|
 |
|
 |
|
|
|
